CCR8 antagonist 1

CAS No. 723304-76-5

CCR8 antagonist 1( LUN04765 )

Catalog No. M29004 CAS No. 723304-76-5

CCR8 antagonist 1 is an antagonist of C-C Motif Chemokine Receptor 8 (CCR8) with a Ki value of 1.6 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 112 In Stock
5MG 103 In Stock
10MG 170 In Stock
25MG 303 In Stock
50MG 428 In Stock
100MG 603 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CCR8 antagonist 1
  • Note
    Research use only, not for human use.
  • Brief Description
    CCR8 antagonist 1 is an antagonist of C-C Motif Chemokine Receptor 8 (CCR8) with a Ki value of 1.6 nM.
  • Description
    CCR8 antagonist 1 is an antagonist of C-C Motif Chemokine Receptor 8 (CCR8) with a Ki value of 1.6 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    LUN04765
  • Pathway
    Autophagy
  • Target
    CCR
  • Recptor
    CCR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    723304-76-5
  • Formula Weight
    495.59
  • Molecular Formula
    C26H29N3O5S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (50.44 mM)
  • SMILES
    O=C(OCC)N1CCC(NS(=O)(=O)C2=CC=C(NC(=O)C=3C=CC=CC3C)C=4C=CC=CC42)CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Leronlimab

    Leronlimab (PRO 140) is a humanized IgG4 anti-CCR5 monoclonal antibody with both anti-HIV and anti-tumor activity, inhibiting CCR-mediated HIV-1 virus and cancer cell metastasis in mouse tumor models. Leronlimab can be used to study HIV, non-alcoholic steatohepatitis (NASH), and breast cancer.

  • SB 328437

    SB 328437 is an effective and selective antagonist of CCR3 (IC50 = 4.5 nM).

  • VER-49009 (b)

    VER-49009 is an effective HSP90 inhibitor(IC50 =25 nM, Kd=78 nM).